IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including ...

Zydus Wellness: Gujarat High Court granted an ad-interim relief to its arm, Zydus Wellness Products, regarding a GST demand ...

Borenstein spoke with TIME about the company’s plans for growth and sustainability, navigating tariffs, and collaborating ...

Earlier in the week, Bernstein upgraded ASML shares to Outperform and named it its top pick among European semiconductor ...

All sectoral indices are trading in the red, with the Media and Realty indices down over 2 percent each. Oil & Gas, Pharma, ...

As per crypto analyst, the crypto market opened the week on a positive note, with Bitcoin and Ethereum leading modest gains.

Josh Allen is dealing with a lingering foot injury, but he's received a positive update ahead of the Bills' playoff contest ...

GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GIUp to $440.0 million in milestone payments eligible to be e ...

Despite "toxic masculinity" being commonly discussed on social media, there is little actual research on this concept. A new ...

Internationally recognized SEO expert and online reputation management authority publishes comprehensive guide to ...

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...